Transatlantic progress in measurement of cognitive outcomes in paediatric oncology trials-Reference-Cited by-同舟云学术

Transatlantic progress in measurement of cognitive outcomes in paediatric oncology trials

Published:2023-02-03 Issue:5 Volume:70 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Thomas Sophie¹²^ORCID,Embry Leanne³,Walsh Karin⁴⁵^ORCID,Bull Kim⁶,Grundy Richard¹²,Kennedy Colin⁶,Lemiere Jurgen⁷,Hernáiz Driever Pablo⁸^ORCID,Limond Jennifer⁹,Chevignard Mathilde¹⁰¹¹¹²,Hardy Kristina⁴⁵

Affiliation:

1. Department of Paediatric Neuropsychology Nottingham Children's Hospital, Queen's Medical Centre Nottingham UK

2. Child Brain Tumour Research Centre, School of Medicine, Queen's Medical Centre University of Nottingham Nottingham UK

3. Pediatric Hematology/Oncology UT Health San Antonio Texas USA

4. Division of Pediatric Neuropsychology Children's National Hospital Washington, DC USA

5. Departments of Psychiatry & Behavioral Medicine and Pediatrics, The George Washington University School of Medicine Washington, DC USA

6. Clinical and Experimental Sciences, Faculty of Medicine University of Southampton Southampton General Hospital UK

7. Department Oncology, Pediatric Hemato‐Oncology, KULeuven University Hospital Leuven Leuven Belgium

8. Department of Pediatric Oncology and Hematology, Berlin Institute of Health Charité‐Universitätsmedizin Berlin Humboldt‐Universität zu Berlin, Berlin Germany

9. Department of Psychology University of Exeter Exeter UK

10. Rehabilitation Department for Children with Acquired Neurological Injury; and Outreach Team for Children and Adolescents with Acquired Brain Injury Saint Maurice Hospitals Saint Maurice France

11. Laboratoire d'Imagerie Biomédicale, LIB Sorbonne Université Paris France

12. GRC24 Handicap Moteur et Cognitif et Réadaptation (HaMCRe) Sorbonne Université Paris France

Abstract

AbstractThe importance of measuring quality of survival within paediatric oncology trials is increasingly recognised. However, capturing neuropsychological outcomes and other aspects of quality of survival in the context of large or multinational trials can be challenging. We provide examples of protocols designed to address this challenge recently employed in clinical trials in the USA and Europe. We discuss their respective strengths and challenges, obstacles encountered and future opportunities for transatlantic collaboration.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.30171

Reference37 articles.

1. Paediatric neuro-oncology rehabilitation in the UK: carer and provider perspectives

2. Assessing the impact of attrition in randomized controlled trials

3. Implementation of multi-site neurocognitive assessments within a pediatric cooperative group: Can it be done?

4. Quality of survival assessment in European childhood brain tumour trials, for children aged 5 years and over

5. Quality of survival assessment in European childhood brain tumour trials, for children below the age of 5 years;Limond J;Eur J Paediatr Neurol,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Risks of Late Effects From Radiation Therapy in Children Versus Adults: Insights From the QUANTEC, HyTEC, and PENTEC Efforts;International Journal of Radiation Oncology*Biology*Physics;2023-12